The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC4XD.L Share News (C4XD)

  • There is currently no data for C4XD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

Wed, 03rd Jan 2024 10:12

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

C4X Discovery Holdings PLC, up 34% at 11.75 pence, 12-month range 7.63p-22.00p. The drug discovery company focussed on immuno-inflammatory diseases receives a USD11.0 million milestone payment from FTSE 100-listed pharmaceutical firm AstraZeneca PLC, following trials of the C4X respiratory disease therapy treatment. The payment stems from preclinical progress of C4X's NRF2 Activator programme, an oral therapy for the treatment of inflammatory and respiratory diseases which AstraZeneca is developing following a agreement between the two in November. In addition to a USD2.0 million upfront payment, the global licencing agreement for the NRF2 Activator entitles C4X to receive up to USD400.0 million in payments following preclinical, clinical development and commercial milestones. The deal also will grant C4X tiered mid-single digit royalties on future sales of the NRF2.

----------

Getech Group PLC, up 29% at 6.75p, 12-month range 4.10p-17.43p. The geo-energy and green hydrogen company says it has won eight new contracts, worth GBP1.8 million in total. The deals comprise of subscriptions to Getech's Globe platform, geoscience data and the purchase of expert consulting services. It expects to recognise GBP600,000 of revenue from these contracts in its 2023 earnings. Acting Chief Executive Officer Richard Bennett says: "Entering 2024 with our substantially reduced costbase, increased order book and growing [annual recurring revenue] means the business is undoubtedly better placed following a year of transition in 2023. We have also invested in expanding our exploration capabilities, targeting resources associated with the energy transition. The recent Cop28 demonstrated again the world's commitment to phasing down fossil fuels and in 2024 we expect to benefit from this by helping our customers locate the subsurface future facing resources such as critical minerals and geothermal projects that are so vital to the energy transition."

----------

AIM - LOSERS

----------

Mkango Resources Ltd, down 7.3% at 9.50p, 12-month range 8.00p-17.41p. The mineral exploration and development company says that its subsidiary Maginito Ltd will partner with CoTec Holdings Corp to roll out scrap magnetic recycling technology in the US. The partnership will focus on promoting HyProMag Ltd's technology. HyProMag is a rare earth magnet recycling company in which Maginito holds a 100% stake, and is commercialising its technology in the UK, Germany and US. The 50-50 joint venture will initially involve a bankable feasibility study using three hydrogen processing of magnet scrap vessels and a magnet manufacturing hub. Following this, Mkango and CoTec will decide whether to proceed with the construction of the US project. Revenue from the project is targeted for either 2025 or 2026. The pair recently issued a request for proposal process from "leading engineering, procurement and construction management providers", and has ordered three HPMS reactors to expedite the US project.

----------

By Greg Rosenvinge, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
29 Nov 2018 12:50

C4X Discovery Partners With Artificial Intelligence Firm GTN

LONDON (Alliance News) - C4X Discovery Holdings PLC said Thursday that it has entered into a drug discovery partnership with GTN Ltd, a company using artificial intelligence to discover new the to

Read more
29 Nov 2018 12:21

C4X enters drug discovery AI deal with GTN

(Sharecast News) - Drug discovery company C4X Discovery Holdings has entered into a partnership with GTN, a new player in the field of drug discovery artificial intelligence, initially focussing on identifying potential small molecule hits against a high-value neurodegeneration target, it announced on Thursday.

Read more
27 Nov 2018 13:21

C4X Discovery Inks Deal With LifeArc To Develop Small Drug Candidates

LONDON (Alliance News) - C4X Discovery Holdings PLC said Tuesday it has entered into a discovery partnership with LifeArc, a UK medical research charity, to develop small molecule drug candidates

Read more
21 Nov 2018 12:41

C4X Discovery Annual Loss Narrows On Next Generation Programmes

LONDON (Alliance News) - C4X Discovery Holdings PLC on Wednesday said its loss narrowed in its recently ended financial year, as revenue multiplied.The drug discovery company said its loss

Read more
5 Oct 2018 11:01

C4X Discovery Raises GBP10.1 Million From Placing And Open Offer (ALLISS)

LONDON (Alliance News) - C4X Discovery Holdings PLC said Thursday it has received valid acceptances for 99,563 open offer shares from qualifying shareholders.This represents about 9.0% of a

Read more
18 Sep 2018 18:23

UPDATE: C4X Discovery Raises GBP11 Million Via Placing And Open Offer (ALLISS)

LONDON (Alliance News) - C4X Discovery Holdings PLC late Tuesday said it raised GBP10.0 million through placing and a further GBP1.0 million via an open offer.The drug discovery company it

Read more
18 Sep 2018 15:18

C4X Discovery To Raise GBP11 Million Through Placing And Open Offer (ALLISS)

LONDON (Alliance News) - C4X Discovery Holdings PLC on Tuesday said it intends to raise GBP10.0 million through placing and a further GBP1.0 million via an open offer.The drug discovery its

Read more
24 Jul 2018 10:02

C4X Discovery Awarded USD480,000 Grant For Cocaine Addiction Treatment

LONDON (Alliance News) - Drug discovery company C4X Discovery Holdings PLC said on Tuesday it has been awarded a USD480,000 grant from the National Institute on Drug Abuse for the company's US

Read more
4 Jul 2018 11:02

C4X Discovery Appoints Eva-Lotta Allan As Chairman

LONDON (Alliance News) - C4X Discovery Holdings PLC said Wednesday it appointed Eva-Lotta Allan as its new chair and Natalie Walter as non-executive director with immediate effect.Allan is

Read more
1 May 2018 11:41

e-Therapeutics Pens Research Collaboration With C4X Discovery

LONDON (Alliance News) - e-Therapeutics PLC and C4X Discovery Holdings PLC on Tuesday announced a research collaboration to look into insights into Parkinson's disease.The partnership,

Read more
29 Mar 2018 10:28

WINNERS & LOSERS SUMMARY: C4X Shares Double On Indivior Licensing Deal

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Wm Morrison

Read more
6 Jan 2017 08:13

C4X Discovery Holdings focuses on early licensing deals to drive revenue

(ShareCast News) - Drug discovery company C4X Discovery Holdings is focusing on early licensing deals to drive revenue as it bids to become the world's most productive drug discovery engine. The AIM-listed company said it shifted focus on generating a high value pre-clinical asset portfolio that wil

Read more
30 Dec 2016 12:01

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
22 Nov 2016 10:52

C4X Discovery Makes Interim CFO Permanent, Appoints Two To Board

Read more
6 Sep 2016 08:23

C4X Discovery Attracts New Investors In GBP5 Million Placing (ALLISS)

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.